Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/23/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. BABA
7. AVGO
8. SPCX
9. DE
10. NTES

Go back to Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)

Zentalis Pharmaceuticals (ZNTL) Announces FDA Lifted Partial Clinical Hold on Azenosertib Studies

September 16, 2024 7:01 AM EDT

Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small... More